Palleon Pharmaceuticals

Palleon Pharmaceuticals is a leading biotechnology company dedicated to developing drugs targeting glycan-mediated immune regulation for the treatment of cancer and inflammatory diseases. The company’s proprietary platform integrates technologies and insights from global scientific leaders in the field of glycoimmunology to overcome historical scientific barriers and develop novel therapies for devastating diseases associated with immune system dysfunction.